| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ISHARES TR | 8,000 | 99,496,000 | 10.36% | Put | |
| 2 | SPDR S&P 500 ETF TR PUT | 3,500 | 72,251,000 | 7.52% | Put | |
| 3 | ALLERGAN PLC | 192,100 | 57,173,000 | 5.95% | ||
| 4 | PFIZER INC | 1,024,013 | 35,625,000 | 3.71% | ||
| 5 | SPDR S&P BIOTECH ETF | 1,500 | 33,063,000 | 3.44% | Put | |
| 6 | GILEAD SCIENCES INC | 320,000 | 31,402,000 | 3.27% | ||
| 7 | TEVA PHARMACEUTICAL INDS LTD | 402,819 | 25,096,000 | 2.61% | ||
| 8 | ABBVIE INC | 407,000 | 23,826,000 | 2.48% | ||
| 9 | TEVA PHARMACEUTICAL INDUSTRIES LTD | 3,500 | 21,805,000 | 2.27% | Call | |
| 10 | MERCK & CO INC | 375,000 | 21,555,000 | 2.24% | ||
| 11 | AMGEN INC | 120,200 | 19,214,000 | 2.00% | ||
| 12 | ENDO INTL | 210,000 | 18,837,000 | 1.96% | ||
| 13 | MYLAN N V | 272,100 | 16,149,000 | 1.68% | ||
| 14 | AUSPEX PHARMACEUTICALS INC | 125,074 | 12,541,000 | 1.31% | ||
| 15 | ORMAT TECHNOLOGIES INC | 80,092 | 12,054,000 | 1.25% | ||
| 16 | AMAG PHARMACEUTICALS INC COM | 200,230 | 10,945,000 | 1.14% | ||
| 17 | ISHARES TR | 300 | 10,303,000 | 1.07% | Put | |
| 18 | BIOMARIN | 80,000 | 9,970,000 | 1.04% | ||
| 19 | NOVARTIS A G | 100,000 | 9,861,000 | 1.03% | ||
| 20 | SELECT SECTOR SPDR TR SBI HEALTHCARE | 1,300 | 9,425,000 | 0.98% | Put | |
| 21 | VALEANT PHARMACEUTICALS INTL | 45,750 | 9,087,000 | 0.95% | ||
| 22 | UNITED THERAPEUTICS | 48,840 | 8,422,000 | 0.88% | ||
| 23 | CLOVIS ONCOLOGY INC | 112,455 | 8,348,000 | 0.87% | ||
| 24 | CELGENE CORP | 70,000 | 8,070,000 | 0.84% | ||
| 25 | VERINT SYS INC COM | 122,304 | 7,574,000 | 0.79% | ||
| 26 | SHIRE PLC | 134,751 | 7,229,000 | 0.75% | ||
| 27 | SEATTLE GENETICS INC | 200,000 | 7,070,000 | 0.74% | ||
| 28 | ISHARES TR | 56,100 | 6,977,000 | 0.73% | ||
| 29 | ARRAY BIOPHARMA INC COM | 923,922 | 6,809,000 | 0.71% | ||
| 30 | BRISTOL MYERS SQUIBB CO | 100,000 | 6,450,000 | 0.67% | ||
| 31 | DYAX CORP COM CVR | 367,556 | 6,158,000 | 0.64% | ||
| 32 | ASTRAZENECA PLC | 86,637 | 5,929,000 | 0.62% | ||
| 33 | CHECK POINT SOFTWARE TECH LT | 71,927 | 5,896,000 | 0.61% | ||
| 34 | INSYS THERAPEUTICS INC NEW COM NEW | 100,000 | 5,813,000 | 0.61% | ||
| 35 | BELLICUM PHARMACEUTICALS INC COM | 249,567 | 5,693,000 | 0.59% | ||
| 36 | CONCERT PHARMACEUTICALS INC COM | 375,000 | 5,679,000 | 0.59% | ||
| 37 | APPLE INC | 42,733 | 5,317,000 | 0.55% | ||
| 38 | Tekmira Pharmaceuticals Corp. | 298,486 | 5,212,000 | 0.54% | ||
| 39 | INSMED INC COM PAR .01 | 250,000 | 5,200,000 | 0.54% | ||
| 40 | KAMADA LTD | 293,727 | 5,167,000 | 0.54% | ||
| 41 | FORWARD PHARMA A/S | 180,000 | 5,098,000 | 0.53% | ||
| 42 | TOWERS WATSON & CO | 38,300 | 5,063,000 | 0.53% | ||
| 43 | VANDA PHARMACEUTICALS INC COM | 543,390 | 5,054,000 | 0.53% | ||
| 44 | AMICUS THERAPEUTICS INC | 450,000 | 4,896,000 | 0.51% | ||
| 45 | RELYPSA INC | 135,000 | 4,869,000 | 0.51% | ||
| 46 | CATALYST PHARMACEUTICALS INC | 1,100,000 | 4,763,000 | 0.50% | ||
| 47 | APPLIED GENETIC TECHNOL CORP | 235,124 | 4,700,000 | 0.49% | ||
| 48 | IMPAX LABORATORIES INC | 100,000 | 4,687,000 | 0.49% | ||
| 49 | MEDIVATION INC | 36,115 | 4,661,000 | 0.49% | ||
| 50 | KYTHERA BIOPHARMACEUTICALS I | 90,000 | 4,514,000 | 0.47% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-15-001551, filed 2015.05.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
